Doug Schenkel
Stock Analyst at Wolfe Research
(3.52)
# 670
Out of 4,804 analysts
66
Total ratings
47.92%
Success rate
32.68%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Outperform | $60 | $43.79 | +37.02% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $59.31 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $40.27 | +48.99% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $20.64 | +35.66% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $203.53 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $123.85 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $1.94 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $191.89 | +48.52% | 2 | Oct 31, 2024 | |
| BRKR Bruker | Downgrades: Peer Perform | n/a | $41.19 | - | 2 | Sep 30, 2024 | |
| A Agilent Technologies | Downgrades: Peer Perform | n/a | $107.05 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $41.43 | +24.31% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $8.67 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $76.30 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $45.50 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $453.55 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $8.45 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $101.34 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.45 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $15.89 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $43.87 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $151.97 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $336.52 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.94 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.58 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.46 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.01 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.96 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.36 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $2.31 | +679.22% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $17.61 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $264.72 | -66.00% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.59 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $219.41 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $66.84 | -76.06% | 2 | Sep 28, 2017 |
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $43.79
Upside: +37.02%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $59.31
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $40.27
Upside: +48.99%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $20.64
Upside: +35.66%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $203.53
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $123.85
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $1.94
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $191.89
Upside: +48.52%
Bruker
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $41.19
Upside: -
Agilent Technologies
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $107.05
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $41.43
Upside: +24.31%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $8.67
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $76.30
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $45.50
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $453.55
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $8.45
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $101.34
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.45
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $15.89
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $43.87
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $151.97
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $336.52
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.94
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.58
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.46
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.01
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.96
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $3.36
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $2.31
Upside: +679.22%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $17.61
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $264.72
Upside: -66.00%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $5.59
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $219.41
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $66.84
Upside: -76.06%